Moving From Simple Capsid Ratios to Drug Product Integrity Evaluation

Time: 3:15 pm
day: Day Two


  • Exploring the need for an industry standard analytical method for full-empty capsid ratio analysis
  • The importance of vector genome integrity and characterising AAV samples
  • Outlining early regulatory involvement and necessary conversations moving forward